Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:42:39.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:14:37.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has added new features for data download options, while several key government health-related links have been removed.
    Difference
    14%
    Check dated 2024-11-23T04:36:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    New resources added from HHS, NIH, NLM, NCBI, and USA.gov, while a previous entry was removed on December 15, 2023.
    Difference
    2%
    Check dated 2024-11-15T23:44:43.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.
    Difference
    16%
    Check dated 2024-11-08T18:21:25.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T10:46:59.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.